Drugs / Sodium dichloroisocyanurate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01350063 | Feb 2011 → May 2012 | diarrheal disease | International Centre for Diarrhoeal Disease Research, Bangladesh | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sodium dichloroisocyanurate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01350063 ↗ |
| Known as | NaDCC | “Aquatabs, an effervescent water purification tablet that utilizes sodium dichloroisocyanurate (NaDCC) as the chlorine donor.” NCT01350063 ↗ |